Release
📈 Stocks
Genezen Partners With InterAct Therapeutics to Advance AAV8 Gene Therapy
(just now)
Genezen expands its CDMO pipeline through a new partnership with InterAct Therapeutics, aiming to scale manufacturing for advanced AAV8-based anti-metastasis gene therapies.